Cargando…
Dose-adjusted EPOCH-rituximab or intensified B-non-Hodgkin lymphoma therapy for pediatric primary mediastinal large B-cell lymphoma. Results from the study B-NHL-BFM-04 and the NHL-BFM registry 2012
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634171/ https://www.ncbi.nlm.nih.gov/pubmed/34498443 http://dx.doi.org/10.3324/haematol.2021.278971 |
_version_ | 1784608082680086528 |
---|---|
author | Knörr, Fabian Zimmermann, Martin Attarbaschi, Andishe Kabíčková, Edita Maecker-Kolhoff, Britta Ruf, Stephanie Kühnle, Ingrid Ebinger, Martin Garthe, Anne-Kathrin Simonitsch-Klupp, Ingrid Oschlies, Ilske Klapper, Wolfram Burkhardt, Birgit Woessmann, Wilhelm |
author_facet | Knörr, Fabian Zimmermann, Martin Attarbaschi, Andishe Kabíčková, Edita Maecker-Kolhoff, Britta Ruf, Stephanie Kühnle, Ingrid Ebinger, Martin Garthe, Anne-Kathrin Simonitsch-Klupp, Ingrid Oschlies, Ilske Klapper, Wolfram Burkhardt, Birgit Woessmann, Wilhelm |
author_sort | Knörr, Fabian |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8634171 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Fondazione Ferrata Storti |
record_format | MEDLINE/PubMed |
spelling | pubmed-86341712021-12-17 Dose-adjusted EPOCH-rituximab or intensified B-non-Hodgkin lymphoma therapy for pediatric primary mediastinal large B-cell lymphoma. Results from the study B-NHL-BFM-04 and the NHL-BFM registry 2012 Knörr, Fabian Zimmermann, Martin Attarbaschi, Andishe Kabíčková, Edita Maecker-Kolhoff, Britta Ruf, Stephanie Kühnle, Ingrid Ebinger, Martin Garthe, Anne-Kathrin Simonitsch-Klupp, Ingrid Oschlies, Ilske Klapper, Wolfram Burkhardt, Birgit Woessmann, Wilhelm Haematologica Letters to the Editor Fondazione Ferrata Storti 2021-09-09 /pmc/articles/PMC8634171/ /pubmed/34498443 http://dx.doi.org/10.3324/haematol.2021.278971 Text en Copyright© 2021 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Letters to the Editor Knörr, Fabian Zimmermann, Martin Attarbaschi, Andishe Kabíčková, Edita Maecker-Kolhoff, Britta Ruf, Stephanie Kühnle, Ingrid Ebinger, Martin Garthe, Anne-Kathrin Simonitsch-Klupp, Ingrid Oschlies, Ilske Klapper, Wolfram Burkhardt, Birgit Woessmann, Wilhelm Dose-adjusted EPOCH-rituximab or intensified B-non-Hodgkin lymphoma therapy for pediatric primary mediastinal large B-cell lymphoma. Results from the study B-NHL-BFM-04 and the NHL-BFM registry 2012 |
title | Dose-adjusted EPOCH-rituximab or intensified B-non-Hodgkin lymphoma therapy for pediatric primary mediastinal large B-cell lymphoma. Results from the study B-NHL-BFM-04 and the NHL-BFM registry 2012 |
title_full | Dose-adjusted EPOCH-rituximab or intensified B-non-Hodgkin lymphoma therapy for pediatric primary mediastinal large B-cell lymphoma. Results from the study B-NHL-BFM-04 and the NHL-BFM registry 2012 |
title_fullStr | Dose-adjusted EPOCH-rituximab or intensified B-non-Hodgkin lymphoma therapy for pediatric primary mediastinal large B-cell lymphoma. Results from the study B-NHL-BFM-04 and the NHL-BFM registry 2012 |
title_full_unstemmed | Dose-adjusted EPOCH-rituximab or intensified B-non-Hodgkin lymphoma therapy for pediatric primary mediastinal large B-cell lymphoma. Results from the study B-NHL-BFM-04 and the NHL-BFM registry 2012 |
title_short | Dose-adjusted EPOCH-rituximab or intensified B-non-Hodgkin lymphoma therapy for pediatric primary mediastinal large B-cell lymphoma. Results from the study B-NHL-BFM-04 and the NHL-BFM registry 2012 |
title_sort | dose-adjusted epoch-rituximab or intensified b-non-hodgkin lymphoma therapy for pediatric primary mediastinal large b-cell lymphoma. results from the study b-nhl-bfm-04 and the nhl-bfm registry 2012 |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634171/ https://www.ncbi.nlm.nih.gov/pubmed/34498443 http://dx.doi.org/10.3324/haematol.2021.278971 |
work_keys_str_mv | AT knorrfabian doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012 AT zimmermannmartin doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012 AT attarbaschiandishe doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012 AT kabickovaedita doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012 AT maeckerkolhoffbritta doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012 AT rufstephanie doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012 AT kuhnleingrid doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012 AT ebingermartin doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012 AT gartheannekathrin doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012 AT simonitschkluppingrid doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012 AT oschliesilske doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012 AT klapperwolfram doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012 AT burkhardtbirgit doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012 AT woessmannwilhelm doseadjustedepochrituximaborintensifiedbnonhodgkinlymphomatherapyforpediatricprimarymediastinallargebcelllymphomaresultsfromthestudybnhlbfm04andthenhlbfmregistry2012 |